acut
respiratori
distress
syndrom
ard
lifethreaten
respiratori
failur
one
challeng
clinic
condit
result
nearli
death
annual
associ
high
morbid
mortal
rate
million
ard
case
annual
worldwid
account
intens
care
unit
admiss
acut
respiratori
distress
syndrom
character
acut
diffus
inflamm
lung
injuri
lead
intens
transepitheli
leukocyt
infiltr
exud
accumul
lung
loss
integr
alveolarcapillari
membran
tissu
damag
acut
lung
injuri
ali
induc
lipopolysaccharid
lp
mice
wellaccept
model
investig
ard
mimic
inflammatori
histolog
chang
observ
diseas
model
lp
stimul
alveolar
macrophag
via
complex
respons
activ
nuclear
factor
kappa
b
cjun
ntermin
kinas
jnk
regul
secret
inflammatori
mediat
cytokin
eg
secret
inflammatori
mediat
trigger
neutrophil
infiltr
alveolar
space
intens
inflammatori
respons
associ
ard
exacerb
despit
advanc
ard
diagnosi
treatment
last
year
treatment
option
limit
pharmacolog
treatment
aim
underli
patholog
proven
effect
punica
granatum
l
pomegran
shown
possess
woundheal
antimicrobi
antioxid
antiinflammatori
properti
antiinflammatori
properti
pomegran
exploit
tradit
medicin
treatment
inflammatori
disord
previous
demonstr
hydroalcohol
extract
pomegran
leav
inhibit
product
decreas
neutrophil
migrat
rat
model
lpsinduc
acut
periton
addit
ethyl
acet
fraction
hydroalcohol
extract
pomegran
leav
effect
treat
lpsinduc
ali
mice
pharmacolog
use
compound
especi
gallotannin
identifi
ethyl
acet
fraction
pomegran
leav
galloylhexahydroxydiphenoyl
hhdp
glucos
identifi
ethyl
acet
fraction
hydrolys
tannin
shown
also
present
pomegran
juic
emblic
leafflow
fruit
eucalyptu
globulu
labil
bark
howev
pharmacolog
activ
remain
undetermin
effect
galloylhhdpglucos
inflammatori
respons
especi
acut
lung
inflamm
report
henc
studi
assess
antiinflammatori
potenti
galloylhhdpglucos
isol
pomegran
leav
lpsinduc
ali
mous
model
hydroalcohol
extract
ethyl
acet
fraction
pomegran
leav
obtain
previous
describ
compound
ethyl
acet
fraction
identifi
previous
describ
ethyl
acet
fraction
separ
chromatographi
silica
gel
mesh
column
cm
elut
crescent
polar
mixtur
nhexaneethylacet
ethylacetatemethanol
fraction
obtain
subject
anoth
round
chromatographi
result
fraction
one
contain
galloylhhdpglucos
puriti
structur
determin
use
hplcdadesiitm
analysi
previous
describ
data
obtain
compar
verifi
previou
studi
investig
chemic
structur
galloylhhdpglucos
figur
anim
care
experiment
procedur
conduct
complianc
rule
british
pharmacolog
societi
ethic
committe
experiment
protocol
approv
intern
ethic
committe
univers
paulo
anim
hous
control
light
h
h
dark
light
temperatur
condit
free
access
water
food
anim
obtain
anim
facil
univers
paulo
paulo
brazil
sixtysix
nonfast
male
inbr
balbc
mice
week
randomli
distribut
six
group
n
lung
bronchoalveolar
lavag
fluid
balf
analyz
mice
anesthet
isoflurano
ali
induc
intratrach
instil
lp
e
coli
mgml
nacl
per
anim
equival
mgkg
vehicletr
mice
use
control
nacl
per
anim
mice
receiv
singl
oral
administr
po
vehicl
salin
mlkg
galloylhhdpglucos
mgkg
mlkg
dexamethason
mgkg
mlkg
h
lp
administr
twentyfour
hour
lp
challeng
mice
weigh
anesthet
thiopent
mgkg
tracheostom
connect
ventil
flexiv
scire
montreal
canada
maintain
tidal
volum
respiratori
frequenc
mlkg
breathesmin
respect
respiratori
mechan
evalu
respiratori
system
elast
er
resist
rr
obtain
use
equat
motion
respiratori
system
previous
describ
tissu
damp
gti
elast
hti
paramet
obtain
zr
data
appli
constant
phase
model
previous
describ
bodi
weight
bw
record
h
h
post
lp
challeng
balf
anesthet
anim
collect
previous
describ
aliquot
balf
use
quantif
leukocyt
rest
centrifug
g
min
supernat
immedi
frozen
store
analysi
separ
seri
experi
lung
collect
anim
whose
balf
collect
process
histolog
analysi
total
cell
count
determin
neubauer
chamber
use
microscop
zeiss
axio
imag
upright
microscop
carl
zeiss
germani
dilut
aliquot
balf
solut
anoth
aliquot
use
differenti
cell
count
previous
describ
left
lung
mg
mechan
homogen
use
tissuelys
ii
bead
mill
qiagen
valencia
ca
stainless
steel
bead
total
rna
extract
use
rnaeasi
mini
kit
qiagen
hilden
germani
sampl
treat
dnase
qiagen
valencia
ca
quantiti
purifi
rna
measur
absorb
use
nanodrop
lite
spectrophotomet
thermofish
scientif
usa
rna
ng
reversetranscript
use
high
capac
cdna
transcript
kit
thermofish
scientif
usa
produc
complementari
dna
cdna
mrna
express
determin
rtqpcr
describ
previous
brief
qpcr
assay
perform
reaction
mixtur
contain
primer
qpcr
master
mix
promega
corpor
cdna
qpcr
assay
carri
flex
thermo
fisher
scientif
usa
use
follow
program
one
cycl
min
follow
cycl
min
gapdh
mrna
use
endogen
refer
gene
mrna
rel
express
calcul
use
method
result
repres
mean
valu
obtain
two
independ
experi
assay
perform
triplic
right
lung
lobe
fix
formaldehyd
h
embed
paraffin
deparaffin
dehydr
previous
describ
section
stain
hematoxylin
eosin
analyz
microscopi
magnif
use
axio
imag
zeiss
microscop
carl
zeiss
criteria
use
histolog
evalu
alveolar
peribronchiolar
inflammatori
infiltr
alveolar
septum
thicken
edema
follow
inflammatori
infiltr
score
establish
absenc
observ
field
mild
observ
field
moder
observ
field
intens
observ
field
densiti
leukocytesunit
area
determin
count
number
cell
integr
eyepiec
fell
area
bronquioli
distal
lung
parenchyma
use
imag
j
program
measur
perform
random
section
per
anim
magnif
leukocyt
count
research
perform
analysi
unawar
experiment
group
design
two
independ
research
perform
blind
analys
discord
third
research
perform
analysi
left
lung
mg
homogen
polytron
pta
brinkmann
instrument
model
pt
ml
protein
extract
buffer
centrifug
min
total
protein
content
lung
homogen
determin
use
bradford
reagent
protein
assay
biorad
result
valu
use
normal
valu
specif
protein
detect
elisa
lung
tissu
lung
protein
level
analyz
use
elisa
kit
r
system
minneapoli
usa
accord
manufactur
instruct
sampl
read
cytokin
compar
standard
curv
pgml
serial
twofold
dilut
result
express
protein
level
pgml
experi
perform
triplic
total
protein
level
measur
use
bradford
method
use
standard
quick
start
bradford
protein
assay
kit
biorad
hercul
ca
usa
accord
manufactur
instruct
absorb
measur
autom
spectrophotomet
nm
read
obtain
compar
standard
curv
albumin
mgml
experi
perform
triplic
subunit
express
lung
tissu
homogen
quantifi
lung
homogen
treat
laemmli
sampl
buffer
contain
dithiothreitol
biorad
protein
concentr
supernat
determin
use
bradford
assay
equal
amount
total
protein
sampl
g
treat
laemmli
buffer
contain
dithiothreitol
mm
sampl
subject
sdspage
bisacrylamid
protein
electrotransf
protein
gel
nitrocellulos
membran
biorad
perform
min
v
constant
nonspecif
protein
bind
nitrocellulos
reduc
preincub
membran
overnight
block
buffer
milktrisbuff
salin
tween
antibodi
use
immunoblot
antiphosphoryl
cell
signal
danver
sigma
aldrich
st
loui
mo
dilut
block
buffer
overnight
membran
wash
min
trisbuff
salin
tween
bound
antibodi
detect
horseradish
peroxidaseconjug
antiigg
visual
chemiluminesc
use
uvitec
uvitec
cambridg
band
intens
quantifi
use
uvitec
imag
program
phosphoryl
express
normal
total
express
raw
cell
cultur
maintain
dmem
medium
thermo
fisher
scientif
usa
contain
fetal
bovin
serum
antibiot
solut
uml
penicillin
g
uml
streptomycin
sulfat
thermo
fisher
scientif
usa
cell
cellswel
treat
eafpg
cell
incub
h
vehicl
dmso
pb
treat
cell
use
control
cultur
well
delic
wash
phosphat
buffer
salin
solut
pb
nacl
kcl
ph
cell
viabil
determin
mtt
assay
brief
cell
incub
mtt
final
concentr
mgml
sigma
aldrich
usa
h
centrifug
rpm
min
room
temperatur
remov
supernat
afterward
form
formazan
crystal
dissolv
ml
dimethyl
sulfoxid
dmso
min
absorb
read
determin
nm
nm
wavelength
refer
result
express
percentag
maxim
valu
posit
control
report
mean
three
independ
assay
standard
deviat
normal
variabl
evalu
use
normal
test
statist
differ
group
analyz
use
oneway
anova
follow
tukey
test
comparison
three
group
gaussian
data
kruskalw
follow
dunn
method
nonparametr
data
percentag
inhibit
calcul
mean
inhibit
obtain
individu
experi
p
valu
consid
statist
signific
data
express
mean
standard
deviat
sd
evalu
total
phosphoryl
level
subunit
jnk
lung
homogen
analyz
possibl
mechan
involv
antiinflammatori
effect
galloylhhdpglucos
figur
anim
ali
exhibit
increas
express
phosphoryl
compar
salinetr
group
contrast
dose
galloylhhdpglucos
block
lpsinduc
activ
galloylhhdpglucosetr
anim
also
present
significantli
reduc
lung
jnk
express
initi
induc
lp
compar
vehicletr
mice
lp
instil
significantli
increas
mrna
express
lung
figur
test
concentr
galloylhhdpglucos
mgkg
dexamethason
significantli
downregul
lung
gene
express
mice
ali
administ
dose
galloylhhdpglucos
dexamethason
effect
gene
express
figur
lpsinduc
increas
protein
level
lung
homogen
sampl
downregul
treatment
either
galloylhhdpglucos
dexamethason
figur
none
dose
galloylhhdpglucos
dexamethason
effect
level
figur
figur
show
effect
galloylhhdpglucos
mgkg
dexamethason
mgkg
bodi
weight
loss
inflammatori
cell
balf
mice
lpsinduc
ali
galloylhhdpglucosetr
anim
present
significantli
reduc
bodi
weight
loss
dose
test
compar
vehicletr
ali
mice
figur
pulmonari
inflamm
also
evalu
balf
figur
mice
lpsinduc
ali
significantli
increas
total
leukocyt
neutrophil
balf
compar
nonali
group
figur
c
contrast
treatment
dose
galloylhhdpglucos
significantli
diminish
total
inflammatori
cell
neutrophil
number
balf
compar
vehicletr
anim
figur
c
similar
effect
note
lpschalleng
mice
treat
dexamethason
differ
observ
number
macrophag
group
total
protein
level
augment
lung
sampl
obtain
mice
ali
figur
hand
treatment
galloylhhdpglucos
significantli
decreas
total
protein
level
lpstreat
mice
compar
vehicletr
lpschalleng
mice
p
anim
ali
exhibit
intens
inflammatorycel
influx
surround
bronchi
figur
galloylhhdpglucos
treatment
mgkg
significantli
reduc
leukocyt
infiltr
compar
infiltr
vehicletr
lp
mice
figur
g
dexamethasonetr
anim
also
display
attenu
lung
inflamm
figur
pulmonari
mechan
data
shown
figur
increas
rr
er
gti
hti
airway
resist
raw
paramet
mice
ali
reflect
lpsinduc
pulmonari
mechan
alter
hand
galloylhhdpglucos
treatment
significantli
reduc
paramet
lpschalleng
anim
compar
vehicletr
lpschalleng
mice
p
figur
cell
viabil
affect
galloylhhdpglucos
except
higher
test
concentr
shown
figur
extract
prepar
pomegran
peel
seed
leav
shown
possess
antiinflammatori
properti
demonstr
previous
hydroalcohol
extract
pomegran
leav
attenu
lpsinduc
periton
decreas
accumul
leukocyt
releas
proinflammatori
mediat
peritoneum
also
show
ethyl
acet
fraction
protect
mice
ali
reduc
lung
inflamm
howev
pharmacolog
properti
galloylhhdpglucos
molecul
present
pomegran
leav
document
studi
therefor
investig
effect
galloylhhdpglucos
mice
lpsinduc
ali
anim
model
lpsinduc
ali
mimic
inflammatori
histolog
chang
observ
ard
lp
stimul
acut
inflamm
activ
lungresid
macrophag
turn
activ
intracellular
mediat
transcript
factor
regul
innat
adapt
immun
function
serv
pivot
mediat
inflammatori
respons
observ
galloylhhdpglucos
block
activ
thu
regul
lung
inflamm
lpsactiv
macrophag
induc
phosphoryl
develop
proinflammatori
profil
gene
express
releas
cytokin
observ
anim
ali
ikb
inhibitor
kinas
b
key
factor
activ
moreov
mitogen
activ
protein
kinas
mapk
one
ikk
activ
differ
stimuli
tlr
other
three
main
mapkinas
pathway
describ
mammalian
cell
extracellular
signalregul
kinas
erk
jnk
pathway
mapk
pathway
jnk
activ
lung
tissu
ard
mice
inhibit
specif
inhibitor
may
significantli
improv
pulmonari
histopatholog
lung
permeabl
rat
reinforc
import
jnk
modul
inflamm
ali
show
lp
activ
jnk
lung
galloylhhdpglucos
treatment
abl
inhibit
lung
jnk
phosphoryl
similar
dexamethason
anim
ali
lpsactiv
macrophag
induc
phosphoryl
lead
develop
proinflammatori
profil
via
express
cytokin
gene
releas
cytokin
therefor
evalu
effect
galloylhhdpglucos
treatment
lung
inflamm
measur
inflammatori
marker
lpsinduc
increas
gene
express
proinflammatori
cytokin
significantli
reduc
galloylhhdpglucos
treatment
previou
studi
hydroalcohol
extract
pomegran
leav
reduc
mrna
express
periton
leukocyt
obtain
rat
lpsinduc
periton
galloylhhdpglucos
may
one
compound
relat
antiinflammatori
effect
previous
observ
treatment
hydroalcohol
extract
ethyl
acet
fraction
pomegran
induc
express
adhes
molecul
endotheli
cell
primari
cytokin
involv
recruit
neutrophil
mainli
via
mapk
pathway
ali
neutrophil
first
cell
recruit
lung
studi
demonstr
galloylhhdpglucos
reduc
neutrophil
migrat
alveoli
marqu
et
al
show
number
periton
leukocyt
especi
neutrophil
reduc
hydroalcohol
extracttr
rat
acut
periton
patient
ard
intens
sign
symptom
depend
caus
sever
diseas
howev
variat
intens
mainli
associ
lung
dysfunct
caus
intens
inflammatori
respons
henc
inflammationmodul
molecul
wide
employ
treatment
ard
patient
studi
observ
galloylhhdpglucos
suppress
lung
inflamm
airway
mice
intratrach
challeng
lp
moreov
treatment
attenu
loss
weight
induc
lp
suggest
treatment
improv
lung
function
also
reduc
system
effect
lp
instil
show
main
therapeut
effect
exhibit
galloylhhdpglucos
reduc
cytokin
product
suppress
mapkinas
activ
result
strongli
suggest
galloylhhdpglucos
possess
potent
antiinflammatori
action
lung
thu
suggest
galloylhhdpglucos
impair
gener
inflammatori
mediat
interf
signal
pathway
leukocyt
pulmonari
dysfunct
caus
intens
inflammatori
respons
relat
lung
failur
result
death
ard
patient
elev
paramet
use
indic
lpsinduc
pulmonari
mechan
complic
attenu
galloylhhdpglucos
improv
lung
function
anim
model
galloylhhdpglucos
exert
antiinflammatori
effect
improv
lung
function
lpsinduc
ali
mous
model
therefor
could
possibl
use
treat
ali
even
inflammatori
disord
dataset
gener
studi
includ
manuscript
anim
care
experiment
procedur
conduct
complianc
rule
british
pharmacolog
societi
ethic
committe
experiment
protocol
approv
intern
ethic
committe
univers
paulo
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
